Clinical trial suggests new cell therapy for relapsed leukemia patients – Stanford Medical Center Report
Stanford Medical Center Report |
Clinical trial suggests new cell therapy for relapsed leukemia patients
Stanford Medical Center Report The therapy is similar to but distinct from CD19-targeted chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, in which a patient's T cells are genetically modified to target a molecule called CD19 on the surface of the cancer cells. This … |
